Publications
October 1, 2021
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
Molecular Cancer Therapeutics, October 28, 2021 Mol Cancer Ther (2021) 20 (12): 2483–2494.
June 1, 2021
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Nature, June 3, 2021
October 1, 2020
Structure, Function, and Therapeutic Use of IgM Antibodies
Antibodies – Special Issue Structure and Function of Antibodies, October 13, 2020 Antibodies 2020, 9(4), 53